IDH1 and cancer: LHGFR0N3C has high LODs for d-2-HG in serum and urine (781.90 μM and 3876.40 μM), which can prevent the false-positive results in patients with d-2-hydroxyglutaric aciduria and/or IDH-mutant cancers (Supplementary Table 4).